Robert Ho

Insider Reports History

Location
Seattle, WA
Signature
/s/ Robert Ho
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Ho:

Company Role Class Num Shares Value Price $ Report Date Ownership
Neoleukin Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 190,000 03 Aug 2021 Direct
Third Harmonic Bio, Inc. Chief Financial Officer Employee Stock Option (right to buy) 136,000 06 Mar 2023 Direct
Third Harmonic Bio, Inc. Chief Financial Officer Employee Option Grant (right to buy) 95,000 25 Oct 2022 Direct
Neoleukin Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 70,000 01 Feb 2022 Direct

Insider Reports Filed by Robert Ho

Symbol Company Period Transactions Value $ Form Type Role Filing Time
THRD Third Harmonic Bio, Inc. 06 Mar 2023 5 $0 4 Chief Financial Officer 08 Mar 2023, 15:58
THRD Third Harmonic Bio, Inc. 25 Oct 2022 1 $0 4 Chief Financial Officer 27 Oct 2022, 16:51
THRD Third Harmonic Bio, Inc. 14 Sep 2022 0 $0 3 Chief Financial Officer 14 Sep 2022, 18:11
NGNE Neoleukin Therapeutics, Inc. 01 Feb 2022 1 $0 4 Chief Financial Officer 02 Feb 2022, 15:36
NGNE Neoleukin Therapeutics, Inc. 03 Aug 2021 1 $0 4 Chief Financial Officer 05 Aug 2021, 16:14